HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account

Clinical Expertise

Dr. Erba's research focus is on clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia. Specifically, he has been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy. Dr. Erba has been an active member of teams of doctors that have brought new treatments to people with AML, such as oral drugs that inactivate FLT3 and IDH.

Location

Duke University Medical Center: Ambulatory Surgery Center, 2400 Pratt St, Durham, NC 27705, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Astellas Pharma
Servier

Follow Us

facebook instagram twitter youtube